Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Benitec Biopharma Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 37 | 57 | +20 |
| Shares | 21.9M | 22.7M | +792.4K (+3.6%) |
| Value | $290.1M | $265.3M | −$24.8M (−8.6%) |
New holders (25)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (5)
Institutions that held Benitec Biopharma Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Millennium Management LLC | 32,046 | $416.9K |
| HRT Financial LP | 25,927 | $337.0K |
| Qube Research & Technologies Ltd | 19,003 | $247.2K |
| SG Americas Securities, LLC | 8,458 | $110.0K |
| Balyasny Asset Management LLC | 2,816 | $36.6K |